CN118240856A - Escherichia coli toxic protein and application and prokaryotic expression method thereof - Google Patents
Escherichia coli toxic protein and application and prokaryotic expression method thereof Download PDFInfo
- Publication number
- CN118240856A CN118240856A CN202410524229.9A CN202410524229A CN118240856A CN 118240856 A CN118240856 A CN 118240856A CN 202410524229 A CN202410524229 A CN 202410524229A CN 118240856 A CN118240856 A CN 118240856A
- Authority
- CN
- China
- Prior art keywords
- hnh
- atpase
- coding box
- protein
- coding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 title claims description 95
- 102000004169 proteins and genes Human genes 0.000 title claims description 93
- 231100000331 toxic Toxicity 0.000 title claims description 18
- 230000002588 toxic effect Effects 0.000 title claims description 18
- 241000588724 Escherichia coli Species 0.000 title claims description 11
- 230000009465 prokaryotic expression Effects 0.000 title description 4
- 230000014509 gene expression Effects 0.000 claims abstract description 30
- 102000004190 Enzymes Human genes 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 18
- 102000004533 Endonucleases Human genes 0.000 claims abstract description 11
- 108010042407 Endonucleases Proteins 0.000 claims abstract description 11
- 108091006112 ATPases Proteins 0.000 claims description 87
- 102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 87
- 239000013598 vector Substances 0.000 claims description 13
- 125000006850 spacer group Chemical group 0.000 claims description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
- 239000013604 expression vector Substances 0.000 claims description 8
- 102000029812 HNH nuclease Human genes 0.000 claims description 7
- 108060003760 HNH nuclease Proteins 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 108020001507 fusion proteins Proteins 0.000 claims description 4
- 102000037865 fusion proteins Human genes 0.000 claims description 4
- 239000012264 purified product Substances 0.000 claims description 2
- 101710163270 Nuclease Proteins 0.000 claims 3
- 230000002616 endonucleolytic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 238000000746 purification Methods 0.000 abstract description 11
- 239000003145 cytotoxic factor Substances 0.000 abstract 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 24
- 239000013612 plasmid Substances 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 18
- 238000003776 cleavage reaction Methods 0.000 description 13
- 230000007017 scission Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 231100000135 cytotoxicity Toxicity 0.000 description 11
- 230000003013 cytotoxicity Effects 0.000 description 11
- 230000004186 co-expression Effects 0.000 description 10
- 230000003993 interaction Effects 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 102000053602 DNA Human genes 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 5
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 5
- 108020004682 Single-Stranded DNA Proteins 0.000 description 5
- 239000013613 expression plasmid Substances 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001641 gel filtration chromatography Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 101710173609 Protein ADP-ribosyltransferase Proteins 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
- 108050008753 HNH endonucleases Proteins 0.000 description 1
- 102000000310 HNH endonucleases Human genes 0.000 description 1
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108091030145 Retron msr RNA Proteins 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000005029 sieve analysis Methods 0.000 description 1
- 230000003007 single stranded DNA break Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention provides a high-efficiency expression purification method of a cytotoxic protein HNH with endonuclease activity, and proves the endonuclease activity of HNH. The implementation of the invention not only optimizes the expression and purification method of HNH, but also provides a potential tool enzyme.
Description
Field of application
The invention relates to the technical field of enzyme and protein expression and purification methods, in particular to an expression and purification method of toxic protein HNH with endonuclease activity.
Background
HNH enzymes, also known as "ββα -me" endonucleases, all members of this family have a highly similar catalytic motif- ββα topology consisting of 30 to 40 amino acids responsible for binding and cleavage of nucleic acids, and are structurally characterized by the folding of three conserved amino acid His-Asn-His residues (H-N-H) into two antiparallel β sheets, an α helix and a β - α -metal topology that binds divalent metal cations, ultimately folding into ββα -metal topology.
The sequence conservation of HNH proteins is manifested by His being conserved at the end of the β1 chain (corresponding to the first letter "H" in HNH), metal ions binding to highly conserved Asn/His residues located within the α -helix (corresponding to the last letter "H" in HNH), conserved Asn at the beginning of the β2 chain (corresponding to the letter "N" in HNH), which typically hydrogen bonds with the backbone atoms next to catalytic His, thus playing an important structural role in fixing the position and orientation of the general bases. When the HNH nuclease functions as a monomer, a single gap is made in the nucleic acid to degrade the exogenous or host genome (Nickase endonuclease), and when functioning as a homodimer, double-stranded DNA breaks are introduced for DNA restriction, integration, recombination, and repair.
Earlier studies show that when HNH protein is expressed by the prokaryote, the experimental phenomenon is that the escherichia coli can be cultured, but once the escherichia coli is expressed by induction, bacterial liquid becomes clear gradually, and cytotoxicity of the HNH protein is estimated initially. Thus, it is a key to improve the expression efficiency of HNH protein to build an expression purification system which does not generate cytotoxicity. In addition, the HNH protein family has a plurality of different sequences, and the identification of the novel HNH protein with endonuclease activity can further enrich the number of tool enzymes, so that more choices are provided for the modification and optimization of the tool enzymes.
Disclosure of Invention
Aiming at the problems existing in the prior art, the embodiment of the invention provides a method for coexpression of HNH protein and ATPase protein in the same open reading frame and obtaining soluble target HNH protein.
The primary object of the present invention is to provide an HNH toxic protein expression vector, which comprises an ATPase coding frame and an HNH coding frame, and the ATPase coding frame and the HNH coding frame can be simultaneously and independently expressed.
Further, the HNH toxic protein expression vector is formed by inserting an ATPase coding frame and an HNH coding frame into any prokaryotic expression vector.
Further, the HNH toxic protein expression vector is formed by inserting ATPase coding frames and HNH coding frames into the positions of the expressible ATPase coding frames and HNH coding frames of any prokaryotic expression vector.
Further, the ATPase coding frame and the HNH coding frame are respectively from an Escherichia coli Retron-Eco4 system.
Further, the ATPase coding box and the HNH coding box are from the same bacterium Retron-Eco4 system.
Further, the ATPase coding frame and the HNH coding frame are from the same strain of bacteria Retron-Eco4 system.
Further, the ATPase-encoded protein and HNH-encoded protein have interactions, and the ATPase-encoded protein inhibits cytotoxicity of the HNH-encoded protein.
Further, the ATPase-encoding and HNH-encoding proteins have unstable interactions or weak binding forces, which separate during molecular sieve chromatography.
In a preferred embodiment, the ATPase coding box or HNH coding box is linked to a tag protein coding box which together with the ATPase coding box or HNH coding box expresses a fusion protein comprising the tag protein and ATPase or HNH, said tag protein being located 5 'or 3' to the ATPase coding box or HNH coding box.
In a preferred embodiment, the tag protein may be one of 6×His, FLAG, or HA.
In a preferred embodiment, the HNH coding box is located downstream of the ATPase coding box, and a spacer sequence is included between the two, which allows independent expression of the HNH coding box and the ATPase coding box.
In a preferred embodiment, the HNH coding box, ATPase coding box, spacer sequence and tag protein coding box are formed as follows: F-ATPase-B-HNH or ATPase-B-HNH-F, wherein F is the coding box of the tag protein, B is the spacer sequence, preferably F is 6XHis, and B is RBS (ribosome binding site).
In a preferred embodiment, the ATPase coding box encodes an amino acid sequence as shown in SEQ ID no2 and the HNH coding box expresses an amino acid sequence as shown in SEQ ID no1.
In a preferred embodiment, the HNH toxic protein expression vector comprises the HNH coding box, the ATPase coding box, the spacer sequence and the tag protein coding box having the structure as shown in SEQ ID NO.3 or SEQ ID NO.4, preferably SEQ ID NO.3.
In a preferred embodiment, the above sequence is inserted between BamHI/HindIII cleavage sites following the first T7 promoter of the pCDFDuet vector.
A method for purifying HNH toxic protein expression, the method comprising the steps of:
1) The HNH coding box and the ATPase coding box are simultaneously and independently expressed in the same cell.
2) And (5) primarily purifying the expression product.
3) The initially purified product was further purified.
In a preferred embodiment, the HNH coding box and the ATPase coding box in step 1) are simultaneously and independently expressed in the same vector.
Further, the ATPase coding box and the HNH coding box in the step 1) are ATPase coding box and HNH coding box from the E.coli Retron-Eco4 system.
Further, the ATPase coding box and the HNH coding box in the step 1) are both ATPase coding box and HNH coding box from the same bacteria Retron-Eco4 system.
Further, the ATPase coding box and the HNH coding box in the step 1) are both ATPase coding box and HNH coding box from the same strain of bacteria Retron-Eco4 system.
Further, the ATPase-encoding box-encoded protein and HNH-encoding box-encoded protein in step 1) have interactions, and the ATPase-encoding box-encoded protein can inhibit cytotoxicity of the HNH-encoding box-encoded protein.
Further, the protein encoded by the ATPase coding box and the protein encoded by the HNH coding box in step 1) have unstable interactions or weak binding forces, and can be separated during molecular sieve chromatography.
Further, in step 1), the ATPase coding box or HNH coding box is linked to a tag protein coding box, which together with the ATPase coding box or HNH coding box expresses a fusion protein comprising the tag protein and ATPase or HNH, which tag protein is located at the 5 'or 3' end of the ATPase coding box.
In a preferred embodiment, the tag protein may be one of 6×His, FLAG, or HA.
In a preferred embodiment, the HNH coding box is located downstream of the ATPase coding box, and a spacer sequence is included between the two, which allows independent expression of the HNH coding box and the ATPase coding box.
In a preferred embodiment, the HNH coding box, ATPase coding box, spacer sequence and tag protein coding box are formed as follows: F-ATPase-B-HNH or ATPase-B-HNH-F, wherein F is the coding box of the tag protein, B is the spacer sequence, preferably F is 6XHis, and B is RBS (ribosome binding site).
In a preferred embodiment, the ATPase coding box encodes an amino acid sequence as shown in SEQ ID no2 and the HNH coding box expresses an amino acid sequence as shown in SEQ ID no1.
In a preferred embodiment, the HNH toxic protein expression vector comprises the HNH coding box, the ATPase coding box, the spacer sequence and the tag protein coding box having the structure as shown in SEQ ID NO.3 or SEQ ID NO.4, preferably SEQ ID NO.3.
In a preferred embodiment, the above sequence is inserted between BamHI/HindIII cleavage sites following the first T7 promoter of the pCDFDuet vector.
In a preferred embodiment, step 3) is performed using gel filtration chromatography.
An endonuclease having the sequence of the amino acid sequence shown in SEQ ID NO. 1.
In a preferred embodiment, the endonuclease has the amino acid sequence shown in SEQ ID NO. 1.
Further, the endonuclease has a nicking enzyme activity that cleaves single-stranded DNA (NICKASE ACTIVITY).
The invention has the following beneficial effects:
1. Provides a novel vector and a purification method for expression and purification of toxic proteins, and improves the expression efficiency of the toxic proteins.
2. A novel enzyme having nicking enzyme activity (NICKASE ACTIVITY) for cleaving single-stranded DNA is provided.
Drawings
The method of the present invention and its advantageous effects will be described in detail below with reference to the accompanying drawings and detailed description.
Fig. 1: the expression plasmid required for cytotoxicity experiment was constructed.
Fig. 2: cytotoxicity test results. The bacterial concentration values gradually decreased from top to bottom, and the images shown are representative of three replicates. (a) HNH is cytotoxic; (B) ATPase inhibits HNH cytotoxicity.
Fig. 3: co-IP experimental results of ATPase and HNH. (A) The detection result of the SDS-PAGE of the co-expression of ATPase-FLAG and HNH-HA; (B) the results of ATPase-FLAG and HNH-HA WESTERN blot.
FIG. 4. Construction of ATPase and HNH co-expression plasmids.
Fig. 5: results of ATPase co-expression with HNH. (A) Co-expression nickel affinity chromatography SDS-PAGE results of the tag band on HNH; (B) Co-expression nickel affinity chromatography SDS-PAGE results of the tag band on ATPase; (C) The result of the purification of the product Superdex200 gel filtration chromatography of the co-expression product of ATPase and HNH is obtained.
Fig. 6: HNH endoenzyme activity results. (A) the presence of Nickase enzyme activities in 100nM HNH protein; (B) effect of different divalent cations on HNH enzyme activity; (C) effect of different nucleotides on HNH enzyme activity; (D) schematic of endonuclease experiment.
Fig. 7: IPTG is added to induce expression, and bacterial liquid is changed. Bacteria became clear after 1h of induction with 0.2mM IPTG added to the left centrifuge tube, and remained cloudy after 1h of non-induced bacteria on the right.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials in the examples described below, unless otherwise specified, were purchased from conventional biochemical reagent stores.
The amino acid sequences of the HNH protein and the ATPase protein in the examples correspond to SEQ ID NO.1 and SEQ ID NO.2 respectively.
SEQ ID NO.1(HNH):
MILKRINKTAEDQFLINFKAQNPNGTWDEFRNHEQGILYKRLKQHICNDQMYLCAYCEIDLDRENEHEIKVEHFKSKSG
SLPGGSNWHLEWSNLLAVCLGGTNTGDDFELPANLSCDSYKSHYEDKNKINDKDWTGKILLPLTLPDAHNFFTFEKVTG
KLLPNESYCNTISIDGKPAAETLSIVTKTIEVLNLNCSRLNNARRKLLFHFNNCARERNLRKLHNLLLQWNQGEPKFFQ
TTRDIIIRDDRICQGLLNGTIRYYPYDVPDYA
SEQ ID NO.2(ATPase):
MEQNLPSRITKLIKKSESGDFASSYQLYKVFGSKEYGVEPDEKMSDYFKELSAKQLEGGQLRVADIHLENYKGFESLIM
DFSMKKNSTILVGNNGCGKSTILDAIQKGLTHLSSRLSTRSHNGDGIEKHELRKGQNYASIAINYDYMGIRFPMIIATT
EPGYEDRAKSNYSGINELGSIFKTAHSINPNVSFPLIAMYTVERANDVSTRDIENSEEIKEAQIWDKFKAYNKSLTGKA
DFKLFFRWFKELIEIENSDNADITALRAEIRAKEKDLDNPLLKALLAENKNSETTKKLLEDHQNSLKVLKEKLNSYYSV
NSKTLHTVEDAMYSFLPGFSNLKLQRAPLDLIVDKNNVSLSVLQLSQGEKTILALIADIARRLTLLNPNSVNPLDGTGI
VLIDEIDLHLHPSWQQNIIPRLEKTFKNIQFIVTTHSPQVCHTIDSQNIWLLKNGQKFKAPKGVRGAISSWVLENLFEV
AQRPPEDKYTKLLQEYKNLVFSEKYASEDARKLGATLSQHFGPDDETLVELKLEIEKRIWEDDFEKDQDYKDDDDKSEQ ID NO.3(6XHis-ATPase-RBS-HNH):
catcatcatcatcatcacagcggcgaaaacctgtattttcagggcgctagcGGATCCATGGAACAGAACTTACCGAGTA
GAATAACTAAATTAATTAAAAAATCGGAAAGCGGCGATTTTGCTTCTTCGTATCAGCTTTATAAAGTATTTGGCTCGAA
AGAGTACGGAGTTGAGCCAGATGAAAAAATGTCTGATTACTTCAAAGAATTATCAGCTAAACAGTTAGAAGGTGGTCAA
CTGAGAGTTGCTGATATTCATTTGGAAAACTACAAAGGGTTTGAGTCCCTAATAATGGATTTTTCCATGAAAAAAAACT
CTACAATTTTAGTAGGAAATAATGGCTGTGGGAAAtcgacGATTCTCGATGCAATCCAGAAGGGGTTAACACATCTATC
CTCGAGATTATCTACTCGCTCGCATAATGGCGATGGTATCGAAAAACATGAGTTAAGAAAAGGACAAAACTATGCATCG
ATCGCTATAAATTACGACTATATGGGAATACGTTTTCCTATGATCATAGCTACAACTGAACCTGGTTATGAGGATAGAG
CAAAAAGTAACTATAGCGGTATTAATGAGTTAGGAAGCATTTTCAAAACAGCCCATTCAATCAATCCAAATGTTTCATT
TCCTTTAATTGCAATGTATACAGTTGAAAGGGCTAATGACGTTTCTACTAGAGATATTGAAaattcAGAAGAAATTAAA
GAAGCTCAAATCTGGGATAAATTCAAAGCATATAATAAGAGCCTGACAGGAAAGGCTGATTTCAAATTATTCTTCAGAT
GGTTTAAAGAACTAATAGAAATCGAAAACTCTGATAACGCTGATATAACAGCATTAAGAGCAGAGATTCGTGCTAAAGA
AAAAGACTTAGACAATCCATTGCTAAAAGCTCTTCTGGCAGAGAATAAAAATTCTGAGACTACTAAAAAATTGTTAGAA
GATCATCAGAACTCTCTGAAAGTTTTAAAAGAGAAATTAAATAGCTATTATTCAGTCAATAGTAAAACATTACACACTG
TTGAAGATGCAATGTATTCTTTCCTTCCTGGTTTTAGCAACCTTAAACTTCAAAGGGCGCCTCTTGATCTGATAGTGGA
TAAGAATAATGTTTCCTTAAGTGTTCTGCAATTATCTCAAGGTGAAAAAACCATTTTAGCATTAATTGCAGATATTGCT
CGTAGATTGACATTGTTAAACCCTAATAGTGTTAACCCTTTGGACGGTACTGGAATTGTATTAATCGATGAAATAGACC
TCCATTTACATCCATCATGGCAGCAAAATATTATTCCTCGTCTTGAGAAAACGTTTAAGAATATTCAATTTATAGTCAC
GACTCATAGTCCACAAGTTTGTCATACTATTGATAGTCAGAATATATGGTTGTTAAAGAATGGCCAAAAGTTTAAAGCA
CCGAAAGGAGTTAGAGGAGCAATATCTTCTTGGGTACTGGAGAACTTGTTCGAAGTTGCTCAAAGGCCGCCAGAGGATA
AGTACACAAAACTCTTACAGGAATATAAAAATTTAGTATTTTCAGAAAAATATGCTAGTGAAGATGCAAGAAAGCTAGG
TGCTACTTTATCCCAACATTTCGGACCGGATGATGAAACCTTAGTTGAGTTAaagctAGAAATTGAAAAAAGAATTTGG
GAGGATGATTTTGAAAAGGATCAAGATTACAAGGACGACGATGACAAGTAAgaattcaatcaataggagaaatcaatGG
ATCCATGATTTTGAAAAGGATCAATAAAACTGCTGAAGATCAATTCTTAATTAATTTTAAAGCTCAAAATCCAAATGGG
ACTTGGGATGAATTTAGGAATCATGAACAAGGTATTTTATATAAGAGGTTAAAGCAACATATTTGCAATGATCAAATGT
ACCTTTGTGCGTATTGTGAGATAGATTTAGATCGAGAAAATGAACATGAAATAAAAGTAGAGCATTTCAAATCTAAATC
TGGTTCGCTCCCTGGTGGAAGTAACTGGCATTTAGAGTGGTCTAATCTCTTAGCTGTATGCCTAGGAGGTACAAATACA
GGTGATGATTTCGAATTACCAGCTAATCTAAGTTGTGATTCATATAAGTCACATTATGAAGACAAAAATAAAATCAATG
ATAAAGACTGGACAGGCAAAATCCTGTTACCTTTAACGCTTCCGGATGCACACAATTTTTTTACTTTCGAGAAAGTTAC
AGGTAAGTTGCTACCTAATGAATCATACTGTAATACTATTAGCATAGATGGTAAACCTGCTGCAGAAACACTAAGTATT
GTAACTAAAACAATAGAAGTTCTAAATTTAAACTGCAGCAGGCTAAATAATGCCAGAAGAAAACTGCTGTTTCACTTTA
ATAATTGCGCACGTGAAAGAAACTTGAGAAAGCTCCATAATCTATTATTACAATGGAATCAAGGTGAGCCTAAATTTTT
CCAAACGACACGAGATATAATAATTCGTGATGATAGAATCTGCCAAGGGTTACTGAACGGAACGATAAGATATTACCCA
TACGATGTTCCAGATTACGCTTAA
SEQ ID NO.4(ATPase-HNH-6×His):
ATGGAACAGAACTTACCGAGTAGAATAACTAAATTAATTAAAAAATCGGAAAGCGGCGATTTTGCTTCTTCGTATCAGC
TTTATAAAGTATTTGGCTCGAAAGAGTACGGAGTTGAGCCAGATGAAAAAATGTCTGATTACTTCAAAGAATTATCAGC
TAAACAGTTAGAAGGTGGTCAACTGAGAGTTGCTGATATTCATTTGGAAAACTACAAAGGGTTTGAGTCCCTAATAATG
GATTTTTCCATGAAAAAAAACTCTACAATTTTAGTAGGAAATAATGGCTGTGGGAAAtcgacGATTCTCGATGCAATCC
AGAAGGGGTTAACACATCTATCCTCGAGATTATCTACTCGCTCGCATAATGGCGATGGTATCGAAAAACATGAGTTAAG
AAAAGGACAAAACTATGCATCGATCGCTATAAATTACGACTATATGGGAATACGTTTTCCTATGATCATAGCTACAACT
GAACCTGGTTATGAGGATAGAGCAAAAAGTAACTATAGCGGTATTAATGAGTTAGGAAGCATTTTCAAAACAGCCCATT
CAATCAATCCAAATGTTTCATTTCCTTTAATTGCAATGTATACAGTTGAAAGGGCTAATGACGTTTCTACTAGAGATAT
TGAAaattcAGAAGAAATTAAAGAAGCTCAAATCTGGGATAAATTCAAAGCATATAATAAGAGCCTGACAGGAAAGGCT
GATTTCAAATTATTCTTCAGATGGTTTAAAGAACTAATAGAAATCGAAAACTCTGATAACGCTGATATAACAGCATTAA
GAGCAGAGATTCGTGCTAAAGAAAAAGACTTAGACAATCCATTGCTAAAAGCTCTTCTGGCAGAGAATAAAAATTCTGA
GACTACTAAAAAATTGTTAGAAGATCATCAGAACTCTCTGAAAGTTTTAAAAGAGAAATTAAATAGCTATTATTCAGTC
AATAGTAAAACATTACACACTGTTGAAGATGCAATGTATTCTTTCCTTCCTGGTTTTAGCAACCTTAAACTTCAAAGGG
CGCCTCTTGATCTGATAGTGGATAAGAATAATGTTTCCTTAAGTGTTCTGCAATTATCTCAAGGTGAAAAAACCATTTT
AGCATTAATTGCAGATATTGCTCGTAGATTGACATTGTTAAACCCTAATAGTGTTAACCCTTTGGACGGTACTGGAATT
GTATTAATCGATGAAATAGACCTCCATTTACATCCATCATGGCAGCAAAATATTATTCCTCGTCTTGAGAAAACGTTTA
AGAATATTCAATTTATAGTCACGACTCATAGTCCACAAGTTTGTCATACTATTGATAGTCAGAATATATGGTTGTTAAA
GAATGGCCAAAAGTTTAAAGCACCGAAAGGAGTTAGAGGAGCAATATCTTCTTGGGTACTGGAGAACTTGTTCGAAGTT
GCTCAAAGGCCGCCAGAGGATAAGTACACAAAACTCTTACAGGAATATAAAAATTTAGTATTTTCAGAAAAATATGCTA
GTGAAGATGCAAGAAAGCTAGGTGCTACTTTATCCCAACATTTCGGACCGGATGATGAAACCTTAGTTGAGTTAaagct
AGAAATTGAAAAAAGAATTTGGGAGGATGATTTTGAAAAGGATCAAGATTACAAGGACGACGATGACAAGTAAgaattc
aatcaataggagaaatcaatGGATCCATGATTTTGAAAAGGATCAATAAAACTGCTGAAGATCAATTCTTAATTAATTT
TAAAGCTCAAAATCCAAATGGGACTTGGGATGAATTTAGGAATCATGAACAAGGTATTTTATATAAGAGGTTAAAGCAA
CATATTTGCAATGATCAAATGTACCTTTGTGCGTATTGTGAGATAGATTTAGATCGAGAAAATGAACATGAAATAAAAG
TAGAGCATTTCAAATCTAAATCTGGTTCGCTCCCTGGTGGAAGTAACTGGCATTTAGAGTGGTCTAATCTCTTAGCTGT
ATGCCTAGGAGGTACAAATACAGGTGATGATTTCGAATTACCAGCTAATCTAAGTTGTGATTCATATAAGTCACATTAT
GAAGACAAAAATAAAATCAATGATAAAGACTGGACAGGCAAAATCCTGTTACCTTTAACGCTTCCGGATGCACACAATT
TTTTTACTTTCGAGAAAGTTACAGGTAAGTTGCTACCTAATGAATCATACTGTAATACTATTAGCATAGATGGTAAACC
TGCTGCAGAAACACTAAGTATTGTAACTAAAACAATAGAAGTTCTAAATTTAAACTGCAGCAGGCTAAATAATGCCAGA
AGAAAACTGCTGTTTCACTTTAATAATTGCGCACGTGAAAGAAACTTGAGAAAGCTCCATAATCTATTATTACAATGGA
ATCAAGGTGAGCCTAAATTTTTCCAAACGACACGAGATATAATAATTCGTGATGATAGAATCTGCCAAGGGTTACTGAA
CGGAACGATAAGATATCACCACCACCACCACCACTAA
SEQ ID NO.5(pCDFDuet vector):
GGGGAATTGTGAGCGGATAACAATTCCCCTGTAGAAATAATTTTGTTTAACTTTAATAAGGAGATATACCATGGGCAGC
AGCAGCCAGGATCCGAATTCGAGCTCGGCGCGCCTGCAGGTCGACAAGCTTGCGGCCGCATAATGCTTAAGTCGAACAG
AAAGTAATCGTATTGTACACGGCCGCATAATCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATT
CCCCATCTTAGTATATTAGTTAAGTATAAGAAGGAGATATACATATGGCAGATCTCAATTGGATATCGGCCGGCCACGC
GATCGCTGACGTCGGTACCCTCGAGTCTGGTTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAGCAA
TAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAACCTCAGGCATTTGAGAAGCACA
CGGTCACACTGCTTCCGGTAGTCAATAAACCGGTAAACCAGCAATAGACATAAGCGGCTATTTAACGACCCTGCCCTGA
ACCGACGACCGGGTCATCGTGGCCGGATCTTGCGGCCCCTCGGCTTGAACGAATTGTTAGACATTATTTGCCGACTACC
TTGGTGATCTCGCCTTTCACGTAGTGGACAAATTCTTCCAACTGATCTGCGCGCGAGGCCAAGCGATCTTCTTCTTGTC
CAAGATAAGCCTGTCTAGCTTCAAGTATGACGGGCTGATACTGGGCCGGCAGGCGCTCCATTGCCCAGTCGGCAGCGAC
ATCCTTCGGCGCGATTTTGCCGGTTACTGCGCTGTACCAAATGCGGGACAACGTAAGCACTACATTTCGCTCATCGCCA
GCCCAGTCGGGCGGCGAGTTCCATAGCGTTAAGGTTTCATTTAGCGCCTCAAATAGATCCTGTTCAGGAACCGGATCAA
AGAGTTCCTCCGCCGCTGGACCTACCAAGGCAACGCTATGTTCTCTTGCTTTTGTCAGCAAGATAGCCAGATCAATGTC
GATCGTGGCTGGCTCGAAGATACCTGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGTTCGCGCTTAGCTGGA
TAACGCCACGGAATGATGTCGTCGTGCACAACAATGGTGACTTCTACAGCGCGGAGAATCTCGCTCTCTCCAGGGGAAG
CCGAAGTTTCCAAAAGGTCGTTGATCAAAGCTCGCCGCGTTGTTTCATCAAGCCTTACGGTCACCGTAACCAGCAAATC
AATATCACTGTGTGGCTTCAGGCCGCCATCCACTGCGGAGCCGTACAAATGTACGGCCAGCAACGTCGGTTCGAGATGG
CGCTCGATGACGCCAACTACCTCTGATAGTTGAGTCGATACTTCGGCGATCACCGCTTCCCTCATACTCTTCCTTTTTC
AATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAAT
AGCTAGCTCACTCGGTCGCTACGCTCCGGGCGTGAGACTGCGGCGGGCGCTGCGGACACATACAAAGTTACCCACAGAT
TCCGTGGATAAGCAGGGGACTAACATGTGAGGCAAAACAGCAGGGCCGCGCCGGTGGCGTTTTTCCATAGGCTCCGCCC
TCCTGCCAGAGTTCACATAAACAGACGCTTTTCCGGTGCATCTGTGGGAGCCGTGAGGCTCAACCATGAATCTGACAGT
ACGGGCGAAACCCGACAGGACTTAAAGATCCCCACCGTTTCCGGCGGGTCGCTCCCTCTTGCGCTCTCCTGTTCCGACC
CTGCCGTTTACCGGATACCTGTTCCGCCTTTCTCCCTTACGGGAAGTGTGGCGCTTTCTCATAGCTCACACACTGGTAT
CTCGGCTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTAAGCAAGAACTCCCCGTTCAGCCCGACTGCTGCGCCTTAT
CCGGTAACTGTTCACTTGAGTCCAACCCGGAAAAGCACGGTAAAACGCCACTGGCAGCAGCCATTGGTAACTGGGAGTT
CGCAGAGGATTTGTTTAGCTAAACACGCGGTTGCTCTTGAAGTGTGCGCCAAAGTCCGGCTACACTGGAAGGACAGATT
TGGTTGCTGTGCTCTGCGAAAGCCAGTTACCACGGTTAAGCAGTTCCCCAACTGACTTAACCTTCGATCAAACCACCTC
CCCAGGTGGTTTTTTCGTTTACAGGGCAAAAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTC
TACTGAACCGCTCTAGATTTCAGTGCAATTTATCTCTTCAAATGTAGCACCTGAAGTCAGCCCCATACGATATAAGTTG
TAATTCTCATGTTAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGA
TCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCG
TGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTC
ACCAGTGAGACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTT
GCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCC
CACTACCGAGATGTCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTG
GCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGT
CGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGA
GACAGAACTTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTA
CCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGC
AGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAG
ATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCG
GCGCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACG
ACTGTTTGCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCG
CGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACA
TCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGG
TTTTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAATTAATACGACTCA
CTATA
SEQ ID NO.6(pET28 vector):
TGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTT
GCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTC
TAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGG
TTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTC
TTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCT
ATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCAGGTGG
CACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAAT
TAATTCTTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGA
AAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCGA
TTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCACCATG
AGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGC
TCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACGCGATCGC
TGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAACAATATTTTCACC
TGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGATCGCAGTGGTGAGTAACCATGCATCATCAGGA
GTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACAT
CATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGC
ACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATTTAATCGCGGCCTA
GAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTGTTTATGTAAGCAGACAGTTTTATTGTTC
ATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAG
ATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCA
AGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCG
TAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTG
CCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAAC
GGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAA
AGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGG
AGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTG
ATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCT
TTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCG
CTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCT
TACGCATCTGTGCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCC
AGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGA
CGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCAC
CGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTG
TTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCG
GTTTTTTCCTGTTTGGTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAG
AGAGGATGCTCACGATACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGT
ATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAG
GGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACG
AAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTC
GCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATC
ATGCGCACCCGTGGGGCCGCCATGCCGGCGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGA
AGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTC
CTCGCCGAAAATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCG
ACGATAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTG
CCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCT
GCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAGTGA
GACGGGCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGC
AGGCGAAAATCCTGTTTGATGGTGGTTAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCG
AGATATCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATTGCGCCCAGCGCCATCTGATCGTTGGCAACCAG
CATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCCAGTCGCCTTCC
CGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAAC
TTAATGGGCCCGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGTCTTC
ATGGGAGAAAATAATACTGTTGATGGGTGTCTGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCT
TCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCACTGACGCGTTGCGCGAGAAGATTGTGCA
CCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGCGCGAGA
TTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTG
CCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCG
CAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAA
CGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGCCATACCGCGAAAGGTTTTGCGC
CATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAGG
CCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCA
CCATACCCACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATA
GGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCTCGATCCCG
CGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAA
GAAGGAGATATACCATGGgccatcatcatcatcatcacagcggcgaaaacctgtattttcagggcgctagcGGATCCGG
CTTACTAAAAGCCAGATAACAGTATGCGTATTTGCGCGCTGATTTTTGCGGTATAAGAATATATACTGATATGTATACC
CGAAGTATGTCAAAAAGAGGTATGCTatgaagcagcgtattacagtgacaGTTGACAGCGACAGCTATCAGTTGCTCAA
GGCATATATGATGTCAATATCTCCGGTCTGGTAAGCACAACCATGCAGAATGAAGCCCGTCGTCTGCGTGCCGAACGCT
GGAAAGCGGAAAATCAGGAAGGGATGGCTGAGGTCGCCCGGTTTATTGAAATGAACGGctcttttgctgacgagaacag
ggGCTGGTGAAatgcagtttaaggtttacacctataaaagagagagccgttatcgtctgtttgtggatgtacagagtga
tattattgacacgcccgggcgacggatggtgatccccctggccagtgcacgtctgctgtcagataaagtctcccgtgaa
ctttacccggtggtgcatatcggggatgaaagctggcgcatgatgaccaccgatatggccagtgtgccggtctccgtta
tcggggaagaagtggctgatctcagccaccgcgaaaatgacatcaaaaacgccattaacctgatgttctggggaatata
aATGTCAGGCTCCCTTATACACAGCCAGTCTGCAGGAATTCCCGACCCATCATCAACGGCGAGGAGGGAATTACCATAC
TGAAACTGTCTCCCAAGACAAGTGTTTTGAACATAGCCGCCGTGGAACAGGATCATCGTGGGGTCTTCAAGTGCATAGC
CGAAAATAAGGCAGGGTCAAGTTTCACAACATCGGAGCTGAAAGTCAACTGAAAGCTTGCGGCCGCACTCGAGCACCAC
CACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAAC
TAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGAT
Example 1HNH cytotoxicity assay and mechanism of toxicity inhibition
In the protein expression process, a target gene of HNH protein (SEQ ID NO. 1) is inserted between BamHI/HindIII cleavage sites of a pET28 vector (SEQ ID NO. 6) to construct a plasmid for expressing HNH protein, the plasmid is transferred into escherichia coli BL21 (DE 3) bacteria for expression, and the fact that normal bacterial plaques can grow on the flat plate is found, and the OD 600 value of the bacteria can be normally cultured to 0.6-0.8 when monoclonal culture is selected. However, once IPTG was added to induce expression, the bacterial solution became clear from turbidity. As shown in the figure: bacteria became clear after 1h of induction with 0.2mM IPTG in the left centrifuge tube, and remained cloudy after 1h of non-induced bacteria on the right (see FIG. 7).
The Retron system acts as a whole in E.coli and there may be cytotoxicity of HNH protein, so we speculate that under normal physiological conditions, if there is no toxicity in the Retron-Eco4 complete system, the presence of a certain component in the system inhibits HNH toxicity. To verify this hypothesis, we performed single component deletion mutations and bacterial toxicity experiments.
In order to identify components of the Retron-Eco4 system that inhibit HNH toxicity, different primers were designed (as in Table 1), retron-Eco4 whole-component plasmids and single-component deletion plasmids (ΔRT, ΔATPase, ΔHNH) were constructed, as shown in FIG. 1, all genes were cloned into pCDFDuet vector and transformed into BL21 (DE 3) bacteria in unison for cytotoxicity testing.
Whereas the effector protein ADP-ribosyl transferase in the Retron-Sen2 system is a low temperature toxic toxin protein, the effector protein ADP-ribosyl transferase of Retron-Eco9 is cytotoxic both at 37℃and at low temperature (below 25 ℃). Thus, in this study, it was investigated whether HNH was toxic at a temperature different from that of 18℃at 37 ℃. Furthermore, since the inducer in the experiment was IPTG, there was some toxicity of IPTG to the growth itself of bacteria, and in order to eliminate this effect, the experiment was conducted with reference to the Retron-Sen2 system of the journal (Jacob Bobonis et al,Bacterial retrons encode phage-defending tripartite toxin–antitoxin systems,2022,Nature) of Nature in 2022, and a non-induced group (no IPTG), a low concentration IPTG group (0.1 mM), and a high concentration IPTG group (1 mM) were set. Three replicates were set for each experimental condition.
Table 1: systematic single component deletion mutant primers
Experimental results fig. 2-a shows: (1) Coli containing HNH plasmid, the bacterial plaque of the low concentration IPTG group and the bacterial plaque of the high concentration IPTG group are obviously reduced compared with the bacterial plaque of the uninduced group, and the morphology is also nonuniform; (2) Bacteria containing Retron-Eco4 complete system plasmids grow well in the uninduced group and the low-concentration IPTG group, and grow poorly in the high-IPTG group because of the toxic effect of IPTG; (3) However, it was still observed that the HNH high IPTG group had a smaller number of bacterial plaques than the Retron-Eco4 high IPTG group, where the toxic effects of high IPTG concentrations on the bacteria could be excluded. Thus, the experimental result shows that HNH has cytotoxicity under different temperature conditions, and the complete Retron-Eco4 system has no cytotoxicity under different temperature conditions.
The bacteria containing ΔRT and ΔHNH plasmids in FIG. 2-B were not significantly cytotoxic after low IPTG induction (IPTG low) compared to the plaques of the complete Retron-Eco4 system (IPTG low) in FIG. 2-A, and were more numerous than the plaques of HNH alone (IPTG low) in FIG. 2-A, consistent with the high IPTG group case; however, bacteria containing ΔATPase plasmids exhibited different sizes of bacterial plaques under different temperature conditions, and the bacterial plaques after high IPTG induction were significantly reduced compared with the complete Retron-Eco4 system. It was then concluded that in the complete system, the toxic effects of HNH are released after ATPase deletion, which can be understood as the toxicity of ATPase to inhibit HNH.
In conclusion, the cytotoxicity experimental research results show that the complete Retron-Eco4 system has no toxicity, the independent expression HNH has cytotoxicity at different temperatures, and ATPase has HNH toxicity inhibition effect at different temperatures, which suggests that ATPase and HNH may have interaction under physiological conditions, and further suggests that the co-expression of ATPase and HNH is an important way for obtaining soluble HNH protein.
Example 2 interaction of HNH with ATPase
The project first constructed pCDFDuet-ATPase-FLAG-HNH-HA expression plasmid, as shown in FIG. 3-A, FLAG tag on the C-terminal band of ATPase and HA tag on the C-terminal band of HA protein. And then the constructed plasmid is transformed into escherichia coli BL21 (DE 3) expression competent cells, 0.2mM IPTG induces and expresses 40-50mL bacterial liquid, after bacterial cells are collected, bacterial cells are crushed by ultrasound on ice, and then the supernatant containing soluble ATPase-FLAG and HNH-HA proteins is obtained by low-temperature centrifugation. And then, utilizing the FLAG tag immunomagnetic beads to adsorb ATPase-FLAG protein, and identifying whether the ATPase-FLAG protein can bind and pull down HNH-HA protein, so as to judge the interaction of the ATPase and HNH protein under physiological conditions.
The SDS-PAGE detection of FIG. 3-A shows that: a theoretical size protein band containing ATPase-FLAG and HNH-HA in the eluted sample of FLAG immunomagnetic beads combined with FIG. 3-B precipitated the FLAG tag protein in both the cleavage supernatant and the Elutation sample, indicating that ATPase-FLAG protein was present in the sample on an objective and efficient precipitation was possible. Subsequent HA precipitation by cleavage of the HNH-HA protein theoretical position on the same membrane revealed that FLAG immunomagnetic bead elution samples contained both ATPase and HNH-HA, which represented that ATPase and HNH had physiological interactions. However, the HNH-HA band was not exposed to the original lysate, and the original HNH content was not high, and the affinity of ATPase was similar to that of the enrichment process. In general, the results of the experiment are consistent with those of the bacterial toxicity experiment and the co-expression experiment, and the fact that ATPase has binding capacity with HNH provides a basis for further optimizing the expression and purification method of HNH protein.
Example 3 optimization of expression purification scheme of HNH protein
Two co-expression plasmids of pCDFDuet-6 XHis-ATPase-HNH and pCDFDuet-ATPase-HNH-6 XHis were constructed first, and the affinity tag was carried on ATPase protein and HNH protein respectively, and the interaction between each other was double verified. The specific steps of protein expression are as follows:
1) Constructing a plasmid. Firstly, constructing two coexpression plasmids of pCDFDuet-6 XHis-ATPase-HNH and pCDFDuet-ATPase-HNH-6 XHis, wherein specific sequences of the 6 XHis-ATPase-HNH and the ATPase-HNH-6 XHis are shown in SEQ ID NO.3 and SEQ ID NO.4 respectively. The sequence of interest was inserted between BamHI/HindIII cleavage sites following the first T7 promoter of the pCDFDuet vector.
2) Plasmid transformation. About 100ng of plasmid is transferred into escherichia coli BL21 (DE 3) expression competent cells, the cells are rapidly placed on ice, the cells are subjected to heat shock at 42 ℃ for 60-90s after being subjected to ice bath for 30min, the cells are placed on the ice for 2-3min, 400 mu L of antibiotic-free LB is added into the cells, and the cells are placed in a shaking table after being uniformly mixed, and are subjected to resuscitative culture for 1h at 37 ℃ and 200 rpm. The culture was centrifuged at 3000rpm for 5min, and after discarding 350. Mu.L of LB, the cell pellet was homogenized with the remaining medium and spread evenly on agar plates of the corresponding plasmid resistance (streptomycin 50. Mu.g/mL), the plates were inverted and incubated overnight at 37 ℃.
3) Culturing in small quantity. The project is selected to be monoclonal in LB with corresponding resistance (50 mug/mL of streptomycin), cultured in a shaking table at 37 ℃ and 220rpm until the OD 600 value of the escherichia coli reaches between 0.6 and 0.8, and then added with IPTG with the final concentration of 0.2mM and induced to express for 12 to 16 hours at 18 ℃.
As shown in fig. 4, the difference is that the affinity tag is attached to ATPase and HNH proteins, respectively, to cross-verify the interaction between the two and compare the enrichment effect. The two plasmids are transformed into expression competent cell BL21 (DE 3), and then the culture of the escherichia coli and the expression of the protein are carried out. And carrying out nickel affinity chromatography SDS-PAGE electrophoresis detection on the expressed protein.
The experimental results are shown in FIG. 5-A, when His 6 tag is carried at the C-terminus of HNH protein, a small amount of expressed HNH protein binds to a corresponding small amount of ATPase protein. When the His 6 tag is placed on the N-terminus of the ATPase protein, the high-expressed ATPase protein can bring out the low-expressed HNH protein (FIG. 5-B). The expression results of the two expression plasmid proteins show that the HNH proteins pulled down by the tag bands on the ATPase proteins are more (about 2-3mg HNH can be obtained by 6L His 6 -ATPase bacteria, about 1-2mg HNH can be obtained by 6L His 6 -HNH bacteria), so that the pCDFDuet-His 6 -ATPase-HNH plasmid is selected for the expression of HNH proteins subsequently.
Subsequently, we further purified the Ni-NTA initially pure product using Superdex TM gel filtration chromatography. As expected, a homogeneous stable complex of ATPase and HNH can be obtained from the initially pure product by gel filtration chromatography, the molecular weight of the ATPase protein is about 62.8kDa, the molecular weight of the HNH protein is about 30.2kDa, and the theoretical peak position is between 11 and 12 mL. As a result, as shown in FIG. 5-C, "Peak1" showed Peak positions between 11 and 12mL, where the theoretical molecular weight of the Peak protein was about 400kDa, and the result of SDS-PAGE was combined to confirm that "Peak1" had and only ATPase protein, and thus "Peak1" was presumed to be hexameric or heptameric ATPase. "Peak 2" is the predominant, most symmetrical protein, with a Peak position of 13-14mL where the theoretical molecular weight of the Peak protein is about 158kDa, and SDS-PAGE results indicate that "Peak 2" has and only ATPase protein, and therefore "Peak 2" is the dimeric ATPase. Peak 3 has a Peak position between 16 and 17mL, where the theoretical molecular weight of the Peak protein is about 29kDa, and SDS-PAGE results show that Peak 3 is mainly monomeric HNH protein.
The co-expression experimental result shows that ATPase and HNH are directly combined, but the combination is unstable or the combination force is not strong, so that the ATPase and HNH can be separated in the molecular sieve analysis process. It is presumed that ATP is not stable, and ATP is continuously consumed during protein purification, and ATPase is subjected to configuration change by ATP hydrolysis, thereby being separated from HNH, and finally, separate HNH protein is obtained. Through the expression purification method, the single HNH protein is successfully obtained, and a foundation is laid for the subsequent HNH enzyme activity research.
EXAMPLE 4 enzyme Activity detection of purified HNH
The genome of the bacterial host and the phage genome are supercoiled, so we have pUC19 plasmid in supercoiled structure as cleavage substrate to examine whether HNH (purified protein) has endonuclease activity and cleave single-or double-stranded DNA. Three groups were set up: supercoiled plasmid (extracted pUC 19), linear plasmid (pUC 19 plasmid treated with 50U commercial EcoRI high fidelity enzyme, linear state), nicked plasmid (pUC 19 treated with 50U commercial BspQI enzyme, nicked state cut into single-stranded gap), correspond to three cases of HNH endo-free enzyme activity, HNH cleavage of double-stranded DNA, HNH cleavage of single-stranded DNA, respectively. Nicked eventually release to an Open spiral state (Open spiral).
As shown in FIG. 6-A, in agarose gel electrophoresis, pUC19 in supercoiled state had the highest electrophoresis rate due to the compact structure, the linearized pUC19 band was positioned in the middle, and pUC19 in open state with loose structure had the lowest electrophoresis rate, and the band was positioned at the top. HNH can cleave 200ng supercoiled pUC19 into Nicked at a protein concentration of 100nM, and 200ng pUC19 can be cleaved almost completely at a concentration of 1. Mu.M, with cleavage products in the Linear state, but mainly in the Nicked state, indicating that HNH has a nicking enzyme activity for cleavage of single-stranded DNA (NICKASE ACTIVITY).
The activity of HNH endonucleases is known to have the characteristic of being dependent on divalent metal ions Mg 2+, so that the influence of some common divalent metal ions on the nicking enzyme activity of HNH is tested next, the control group is untreated pUC19 and a reaction system added with a metal ion chelating agent EDTA, and the experimental group contains 1mM metal ions, so that as shown in FIG. 6-B, the cleavage activity of HNH can be promoted by Mg 2+、Mn2 +、Ca2+、Ni2+ except Zn 2+.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to the embodiments described above will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. An HNH toxic protein expression vector comprising an ATPase coding box and an HNH nuclease coding box, wherein the ATPase coding box and HNH nuclease coding box are simultaneously independently expressible.
2. The vector of claim 1, wherein the ATPase coding box and HNH coding box nucleases are both ATPase coding box and HNH nuclease coding box from e.coli Retron-Eco4 system.
3. The vector of claim 1, wherein the ATPase coding box is linked to a tag protein coding box, which together with the ATPase coding box expresses a fusion protein comprising the tag protein and the ATPase.
4. The vector of claim 1, wherein the HNH coding box nuclease is downstream of the ATPase coding box and comprises a spacer sequence therebetween, said spacer sequence allowing independent expression of the HNH nuclease coding box and the ATPase coding box.
5. A method for purifying HNH toxic protein expression, the method comprising the steps of:
1) The HNH nuclease coding frame and the ATPase coding frame are simultaneously and independently expressed in the same cell.
2) And (5) primarily purifying the expression product.
3) The initially purified product was further purified.
6. The method according to claim 5, wherein the HNH nuclease coding box and the ATPase coding box in step 1) are simultaneously and independently expressed in the same vector.
7. The method according to claim 5, wherein the ATPase coding box and the HNH coding box in step 1) are ATPase nuclease coding box and HNH coding box from the E.coli Retron-Eco4 system.
8. The method according to claim 5, wherein the ATPase coding box in step 1) is linked to a tag protein coding box, and the tag protein coding box and the ATPase coding box together express a fusion protein comprising the tag protein and the ATPase.
9. An endonuclease, the sequence of which comprises an amino acid sequence as shown in the sequence SEQ ID NO. 1.
10. Use of a protein comprising the amino acid sequence shown in SEQ ID No.1 for the preparation of an endonucleolytic enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410524229.9A CN118240856A (en) | 2024-04-29 | 2024-04-29 | Escherichia coli toxic protein and application and prokaryotic expression method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410524229.9A CN118240856A (en) | 2024-04-29 | 2024-04-29 | Escherichia coli toxic protein and application and prokaryotic expression method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118240856A true CN118240856A (en) | 2024-06-25 |
Family
ID=91560691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410524229.9A Pending CN118240856A (en) | 2024-04-29 | 2024-04-29 | Escherichia coli toxic protein and application and prokaryotic expression method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118240856A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210130833A1 (en) * | 2019-10-30 | 2021-05-06 | The Broad Institute, Inc. | Bacterial defense systems and methods of identifying thereof |
CN117448368A (en) * | 2023-11-03 | 2024-01-26 | 尚纯生物科技(武汉)有限公司 | Method for preparing recombinant deoxyribonuclease by prokaryotic expression |
-
2024
- 2024-04-29 CN CN202410524229.9A patent/CN118240856A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210130833A1 (en) * | 2019-10-30 | 2021-05-06 | The Broad Institute, Inc. | Bacterial defense systems and methods of identifying thereof |
CN117448368A (en) * | 2023-11-03 | 2024-01-26 | 尚纯生物科技(武汉)有限公司 | Method for preparing recombinant deoxyribonuclease by prokaryotic expression |
Non-Patent Citations (3)
Title |
---|
ANSGAR J. POMMER ET AL.: "Mechanism and Cleavage Specificity of the H-N-H Endonuclease Colicin E9", 《JOURNAL OF MOLECULAR BIOLOGY》, vol. 314, no. 4, 31 December 2001 (2001-12-31), pages 735 - 749, XP004466209, DOI: 10.1006/jmbi.2001.5189 * |
MILLMAN, A. ET AL.: "retron system putative HNH endonuclease [Escherichia coli]", 《GENBANK》, 12 June 2023 (2023-06-12), pages 1 * |
RIA WESTON ET AL.: "ZRANB3 is a structure-specific ATP-dependent endonuclease involved in replication stress response", 《GENES & DEVELOPMENT》, vol. 26, no. 14, 15 July 2012 (2012-07-15), pages 1558 - 1572 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Crameri et al. | Molecular evolution of an arsenate detoxification pathway by DNA shuffling | |
CN110229799B (en) | Argonaute protein mutant and application thereof | |
KR101729361B1 (en) | Bacterial host strain expressing recombinant dsbc and having reduced tsp activity | |
JP2000050888A (en) | New escherichia coli/host vector system selected by complementation of auxotrophy, but not selected by utilization of antibiotics | |
US6949362B2 (en) | Rhodococcus cloning and expression vectors | |
CN112322639A (en) | P-nitrophenol degrading enzyme gene group expressed in escherichia coli and application thereof | |
CN113136374A (en) | Preparation and application of recombinant mutant Tn5 transposase | |
JP5757580B2 (en) | Novel extracellular secretory nuclease | |
Rogers et al. | Cloning of the exonuclease III gene of Escherichia coli | |
CN116286931B (en) | Double-plasmid system for rapid gene editing of Ralstonia eutropha and application thereof | |
CN117448368A (en) | Method for preparing recombinant deoxyribonuclease by prokaryotic expression | |
CN116376945B (en) | I-type caspase gene insertion tool and application | |
EP0877084B1 (en) | Thermostable diaphorase gene | |
CN112029744A (en) | DNA polymerase and its coding gene, preparation method and PCR application | |
CN118240856A (en) | Escherichia coli toxic protein and application and prokaryotic expression method thereof | |
CN114645033B (en) | Nucleoside triphosphate hydrolase and purification method and application thereof | |
Schweizer et al. | Cloning and nucleotide sequence of the glpD gene encoding sn-glycerol-3-phosphate dehydrogenase of Pseudomonas aeruginosa | |
CN112813088B (en) | Preparation method of recombinant DpnI restriction enzyme | |
CN115896063A (en) | High-fidelity Pfu DNA polymerase mutant, preparation method and application thereof | |
CN114230644A (en) | GP32 protein mutant, recombinant vector, and construction method and application thereof | |
CN115785283A (en) | PAG-Tn5 mutant and application thereof | |
JP2011503176A (en) | Method for producing and purifying macromolecular complex | |
US11697805B2 (en) | High-fidelity polymerase with preference for gapped DNA and use thereof | |
CN114250208B (en) | Preparation and application of high-salt-resistant high-activity DNase I mutant | |
CN117187210B (en) | Mutant Bst DNA polymerase large fragment and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |